3 March 2024 in NeuroImage
Posterior cortical atrophy (PCA) and dementia with Lewy bodies (DLB) show distinct atrophy and overlapping hypometabolism profiles, but it is unknown how disruptions in structural and functional connectivity compare between these disorders and whether breakdowns in connectivity relate to either atrophy or hypometabolism. Thirty amyloid-positive PCA patients, 24 amyloid-negative DLB patients and 30 amyloid-negative cognitively unimpaired (CU) healthy individuals were recruited at Mayo Clinic, Rochester, MN, and underwent a 3T head MRI, including structural MRI, resting state functional MRI (rsfMRI) and diffusion tensor imaging (DTI) sequences, as well as [18F] fluorodeoxyglucose (FDG) PET. We assessed functional connectivity within and between 12 brain networks using rsfMRI and the CONN functional connectivity toolbox and calculated regional DTI metrics using the Johns Hopkins atlas. Multivariate linear-regression models corrected for multiple comparisons and adjusted for age and sex compared DTI metrics and within-network and between-network functional connectivity across groups. Regional gray-matter volumes and FDG-PET standard uptake value ratios (SUVRs) were calculated and analyzed at the voxel-level using SPM12. We used univariate linear-regression models to investigate the relationship between connectivity measures, gray-matter volume, and FDG-PET SUVR. On DTI, PCA showed degeneration in occipito-parietal white matter, posterior thalamic radiations, splenium of the corpus collosum and sagittal stratum compared to DLB and CU, with greater degeneration in the temporal white matter and the fornix compared to CU. We observed no white-matter degeneration in DLB compared to CU. On rsfMRI, reduced within-network connectivity was present in dorsal and ventral default mode networks (DMN) and the dorsal-attention network in PCA compared to DLB and CU, with reduced within-network connectivity in the visual and sensorimotor networks compared to CU. DLB showed reduced connectivity in the cerebellar network compared to CU. Between-network analysis showed increased connectivity in both cerebellar-to-sensorimotor and cerebellar-to-dorsal attention network connectivity in PCA and DLB. PCA showed reduced anterior DMN-to-cerebellar and dorsal attention-to-sensorimotor connectivity, while DLB showed reduced posterior DMN-to-sensorimotor connectivity compared to CU. PCA showed reduced dorsal DMN-to-visual connectivity compared to DLB. The multimodal analysis revealed weak associations between functional connectivity and volume in PCA, and between functional connectivity and metabolism in DLB. These findings suggest that PCA and DLB have unique connectivity alterations, with PCA showing more widespread disruptions in both structural and functional connectivity; yet some overlap was observed with both disorders showing increased connectivity from the cerebellum.
15 March 2023 in European Journal of Neurology
27 May 2026 in European Journal of Nuclear Medicine and Molecular Imaging
Background: Females consistently demonstrate greater tau Positron Emission Tomography (PET) tracer signal. Although interpreted as reflecting greater Alzheimer disease (AD) pathology, it’s unclear whether differences arise from biological mechanisms or methodological factors. Microtubule binding region tau species containing residue 243 (MTBR-tau243) in cerebrospinal fluid (CSF) is a biomarker of aggregated tau but avoids PET limitations such as off-target binding. Comparing tau-PET and CSF MTBR-tau243, including sex interactions, can help elucidate the origin of sex differences in tau. Purpose: Conduct a cross-sectional analysis of CSF MTBR-tau243 and tau-PET by sex in the Swedish BioFINDER-2 (BioFINDER-2) Study and Charles F. and Joanne Knight Alzheimer Disease Research Center (Knight-ADRC). Methods: Participants had CSF MTBR-tau243, tau-PET, and Aβ status defined by the CSF Aβ42/40 ratio. Tau-PET was measured using [ 18 F]Flortaucipir (Knight-ADRC, N = 219) and [ 18 F]RO948 (BioFINDER-2, N = 446). We tested the interaction between sex and CSF MTBR-tau243 on tau-PET burden in a temporal meta region-of-interest (ROI) across all participants and in Aβ-positive participants. Results: In both cohorts, CSF MTBR-tau243 was associated with tau-PET temporal meta-ROI burden (BioFINDER-2: β = 1.1, p = < 0.0001 and Knight-ADRC: β = 0.7, p = < 0.0001), and this association did not differ by sex (BioFINDER-2 β = 0.04, p = 0.6 and Knight-ADRC: β = 0.009, p = 0.9). Among Aβ-positive subgroups, results remained consistent for the main effect (BioFINDER-2: β = 1.1, p = < 0.0001 and Knight-ADRC: β = 0.7, p = < 0.0001) and interaction (BioFINDER-2: β = 0.04, p = 0.7 and Knight-ADRC: β = 0.06, p = 0.6). Conclusion: The lack of sex moderating the association between tau-PET and CSF MTBR-tau243 indicates that higher tau-PET signal in females reflects greater susceptibility to tau pathology rather than a methodological artifact.
22 December 2023 in Journal of Alzheimer’s Disease
Background: Posterior cortical atrophy (PCA) and logopenic progressive aphasia (LPA) are two common atypical Alzheimer’s disease (AD) variants. Little is known about behavioral and neuropsychiatric symptoms or activities of daily living (ADLs) in PCA and LPA, and whether they differ across syndromes. Objective: To characterize the behavioral and neuropsychiatric profiles and ADLs of PCA and LPA and compare presence/absence and severity of symptoms between syndromes. Methods: Seventy-eight atypical AD patients, 46 with PCA and 32 with LPA, completed the Neuropsychiatric Inventory Questionnaire (NPI-Q) and Cambridge Behavioral Inventory-Revised (CBI-R) at baseline and longitudinally over-time. Mann-Whitney U and Fisher’s Exact Tests assessed for differences in symptoms between the two syndromes with significance set at p ≤0.01. To eliminate demographic differences as confounders the groups were matched, and differences reanalyzed. Results: PCA were younger at onset ( p = 0.006), at time of baseline assessment ( p = 0.02) and had longer disease duration ( p = 0.01). Neuropsychiatric symptoms were common in PCA and LPA, although more common and severe in PCA. At baseline, PCA had a higher NPI-Q total score ( p = 0.01) and depression subscore ( p = 0.01) than LPA. Baseline total CBI-R scores were also higher in PCA than LPA ( p = 0.001) with PCA having worse scores in all 10 CBI-R categories. Longitudinally, there was no difference between groups on the NPI-Q. However, on the CBI-R, PCA had faster rates of worsening on self-grooming ( p = 0.01) and self-dressing ( p = 0.01) compared to LPA. Conclusions: Behavioral and neuropsychiatric symptoms are common in PCA and LPA although these symptoms are more common and severe in PCA.
1 December 2024 in Alzheimer's & Dementia
Background: The prevalence of Alzheimer disease (AD) is growing rapidly within the aging population with over five million people currently affected in the United States. Of these 5 million people, approximately two‐thirds are females. Prior investigations have demonstrated that females have a higher likelihood of developing AD when compared to men. The present study sought to investigate participants from the Charles F. and Joanne Knight Alzheimer Disease Research Center (ADRC) to determine if sex impacts an individual’s risk of developing dementia.Method: 3231 prospectively recruited participants from were classified as demented or non‐demented based on scores on the Clinical Dementia Rating ® (CDR®). Of the 3231 participants, 58.4 percent were female. Cox proportional hazards models were utilized to compare the rate of developing dementia as a function of self‐reported sex. Models additionally determine if apolipoprotein ε4 (APOE) carriers were at a greater risk of developing dementia. We further evaluated the interaction between sex and APOE status and the likelihood of developing dementia. Baseline age was included as an additional covariate.Results: Participants had mean of 5.92 years of longitudinal cognitive follow‐up. Females did not demonstrate an increased risk of developing dementia compared to males (Hazard ratio = 0.874, p = 0.149). Age at baseline was a significant predictor of conversion to dementia (Hazard ratio = 1.100, p≤0.001), as was ε4 carriers status (Hazard ratio = 1.64, p≤0.001). The interaction between female sex and APOE status was not a significant predictor of conversion to dementia (Hazard ratio = 1.034, p = 0.863).Conclusion: Female participants did not demonstrate an increased risk of developing all cause dementia compared to male participants.
24 December 2025 in Alzheimer's & Dementia
Background: Prior research, replicated across multiple cohorts, has shown sex differences in tau Positron Emission Tomography (PET), with females exhibiting greater tau tracer binding in medial temporal and neocortical regions, particularly in those with positive amyloid‐beta (Aβ) biomarkers. Although typically interpreted as a potentiation of Alzheimer disease (AD) pathology, it remains unclear whether PET methodological factors or underlying biological mechanisms contribute to these observed sex differences. Microtubule binding region tau species containing residue 243 (MTBR‐tau243) in cerebrospinal fluid (CSF) is a biomarker of AD tau pathology and has been shown to be associated with tau‐PET. However, the potential relationship between MTBR‐tau243 and the observed sex differences in tau‐PET, remain unexplored. To address this gap, we conducted a cross‐sectional analysis of CSF MTBR‐tau243 and tau‐PET by sex in two cohorts: participants from the Swedish BioFINDER‐2 Study and Charles F. and Joanne Knight Alzheimer Disease Research Center (Knight‐ADRC). Method: Participants were required to have baseline data for both CSF MTBR‐tau243 and tau‐PET, as well as Aβ status defined by the CSF Aβ42/40 ratio. Tau‐PET was measured using the Flortaucipir tracer in the Knight‐ADRC cohort and the RO948 tracer in the BioFINDER‐2 cohort. In both cohorts, clinical diagnoses were reviewed to identify cases of AD dementia or other dementias. The main analysis of interest was whether there was a significant interaction between sex and CSF MTBR‐tau243 in predicting a temporal meta‐ROI, with additional analyses examining this interaction in Aβ‐positive participants. Result: In both cohorts there were significant associations between CSF MTBR‐tau243 and the temporal meta‐ROI (BioFINDER‐2: t = 17.1, p < 0.001, Knight‐ADRC: t=11.0, p <0.001). This association was not different by sex (BioFINDER‐2: t = 0.54, p = 0.6, Knight‐ADRC: t=0.1, p = 0.9) (Figure 1). This finding remained consistent within the Aβ‐positive subsets of both cohorts (Figure 2). Conclusion: Across two cohorts we found that sex did not moderate the relationship between tau‐PET and CSF MTBR‐tau243, two distinct markers of aggregated tau pathology. This suggests the sex effects found in tau‐PET likely represent a true biological finding not specifically tied to tau‐PET methodology.